Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit
Hematology/Oncology and Stem Cell Therapy · 2018-10 · 11 (4) · 206-218
DOI: 10.1016/j.hemonc.2018.03.003 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2018-10. Verfasst von Nassar Al-Zubaidi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, United States. Hauptthemen laut MEDLINE: Hospital Mortality, Intensive Care Units. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Purpose
Several studies showed conflicting results about prognosis and predictors of outcome of critically ill patients with hematological malignancies (HM). The aim of this study is to determine the hospital outcome of critically ill patients with HM and the factors predicting the outcome. Methods and materials: All patients with HM admitted to MICU at a tertiary academic medical center were enrolled. Clinical data upon admission and during ICU stay were collected. Hospital, ICU, and 6 months outcomes were documented.
Results
There were 130 HM patients during the study period. Acute Leukemia was the most common malignancy (31.5%) followed by Non-Hodgkin’s Lymphoma (28.5%). About 12.5% patients had autologous HSCT and 51.5% had allogeneic HSCT. Sepsis was the most common ICU diagnosis (25.9%). ICU mortality and hospital mortality were 24.8% and 45.3%, respectively. Six months mortality (available on 80% of patients) was 56.7%. Hospital mortality was higher among mechanically ventilated patients (75%). Using multivariate analysis, only mechanical ventilation (OR of 19.0, CI: 3.1–117.4, P : 0.001) and allogeneic HSCT (OR of 10.9, CI: 1.8–66.9, P : 0.01) predicted hospital mortality.
Conclusion
Overall hospital outcome of critically ill patients with HM is improving. However those who require mechanical ventilation or underwent allogeneic HSCT continue to have poor outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, United States.
- Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, MI, United States. Electronic address: asoubani@med.wayne.edu.
Zitieren
APA
Al-Zubaidi, N., Shehada, E., Alshabani, K., ZazaDitYafawi, J., Kingah, P., & Soubani, A. O. (2018). Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit. Hematology/Oncology and Stem Cell Therapy, 11(4), 206-218. https://doi.org/10.1016/j.hemonc.2018.03.003
Vancouver
Al-Zubaidi N, Shehada E, Alshabani K, ZazaDitYafawi J, Kingah P, Soubani AO. Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit. Hematology/Oncology and Stem Cell Therapy. 2018;11(4):206-218. doi:10.1016/j.hemonc.2018.03.003
BibTeX
@article{AlZubaidi2018,
author = {Al-Zubaidi, Nassar and Shehada, Emad and Alshabani, Khaled and ZazaDitYafawi, Jihane and Kingah, Pascal and Soubani, Ayman O},
title = {Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit},
journal = {Hematology/Oncology and Stem Cell Therapy},
year = {2018},
volume = {11},
number = {4},
pages = {206--218},
doi = {10.1016/j.hemonc.2018.03.003}
}
EUVIMED